Clinical Trial Update: Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of concomitant chemoradiotherapy with weekly paclitaxel and vinorelbine plus granulocyte colony-stimulating…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
• PACLITAXEL (PACLITAXEL)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED